Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
Giles
T D
TD
School of Medicine in New Orleans, Louisiana State University Medical Center, 70112-2822, USA.
D000042:Absorption; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D001682:Biological Availability; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000378:metabolism; D020748:Mibefradil; D013764:Tetrahydronaphthalenes / Q000494:pharmacology* / Q000627:therapeutic use
D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil